Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 292.4 SEK 0.62% Market Closed
Market Cap: 100.6B SEK
Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?
Write Note

Wall Street
Price Targets

SOBI Price Targets Summary
Swedish Orphan Biovitrum AB (publ)

Wall Street analysts forecast SOBI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOBI is 382.59 SEK with a low forecast of 277.75 SEK and a high forecast of 577.5 SEK.

Lowest
Price Target
277.75 SEK
5% Downside
Average
Price Target
382.59 SEK
31% Upside
Highest
Price Target
577.5 SEK
98% Upside
Swedish Orphan Biovitrum AB (publ) Competitors:
Price Targets
VICO
Vicore Pharma Holding AB
275% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
32% Upside
RPTX
Repare Therapeutics Inc
325% Upside
CRVO
Diffusion Pharmaceuticals Inc
513% Upside
VYGR
Voyager Therapeutics Inc
211% Upside
BONEX
Bonesupport Holding AB
5% Upside
ARMP
Armata Pharmaceuticals Inc
217% Upside
MYGN
Myriad Genetics Inc
61% Upside

Revenue
Forecast

Revenue Estimate
Swedish Orphan Biovitrum AB (publ)

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s revenue is 27%. The projected CAGR for the next 3 years is 13%.

27%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Swedish Orphan Biovitrum AB (publ)

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s operating income is 54%. The projected CAGR for the next 3 years is 29%.

54%
Past Growth
29%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Swedish Orphan Biovitrum AB (publ)

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s net income is 57%. The projected CAGR for the next 3 years is 46%.

57%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SOBI's stock price target?
Price Target
382.59 SEK

According to Wall Street analysts, the average 1-year price target for SOBI is 382.59 SEK with a low forecast of 277.75 SEK and a high forecast of 577.5 SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s revenue is 27%. The projected CAGR for the next 3 years is 13%.

What is Swedish Orphan Biovitrum AB (publ)'s Operating Income forecast?
Projected CAGR
29%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s operating income is 54%. The projected CAGR for the next 3 years is 29%.

What is Swedish Orphan Biovitrum AB (publ)'s Net Income forecast?
Projected CAGR
46%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s net income is 57%. The projected CAGR for the next 3 years is 46%.

Back to Top